Abstract:Background: Diabetic kidney disease (DKD) and diabetic retinopathy (DR) are major diabetic microvascular complications, contributing significantly to morbidity, disability, and mortality worldwide. The kidney and the eye, having similar microvascular structures and physiological and pathogenic features, may experience similar metabolic changes in diabetes. Objective: This study aimed to use machine learning (ML) methods integrated with metabolic data to identify biomarkers associated with DKD and DR in a multiethnic Asian population with diabetes, as well as to improve the performance of DKD and DR detection models beyond traditional risk factors. Methods: We used ML algorithms (logistic regression [LR] with Least Absolute Shrinkage and Selection Operator and gradient-boosting decision tree) to analyze 2772 adults with diabetes from the Singapore Epidemiology of Eye Diseases study, a population-based cross-sectional study conducted in Singapore (2004-2011). From 220 circulating metabolites and 19 risk factors, we selected the most important variables associated with DKD (defined as an estimated glomerular filtration rate <60 mL/min/1.73 m 2 ) and DR (defined as an Early Treatment Diabetic Retinopathy Study severity level ≥20). DKD and DR detection models were developed based on the variable selection results and externally validated on a sample of 5843 participants with diabetes from the UK biobank (2007-2010). Machine-learned model performance (area under the receiver operating characteristic curve [AUC] with 95% CI, sensitivity, and specificity) was compared to that of traditional LR adjusted for age, sex, diabetes duration, hemoglobin A 1c , systolic blood pressure, and BMI. Results: Singapore Epidemiology of Eye Diseases participants had a median age of 61.7 (IQR 53.5-69.4) years, with 49.1% (1361/2772) being women, 20.2% (555/2753) having DKD, and 25.4% (685/2693) having DR. UK biobank participants had a median age of 61.0 (IQR 55.0-65.0) years, with 35.8% (2090/5843) being women, 6.7% (374/5570) having DKD, and 6.1% (355/5843) having DR. The ML algorithms identified diabetes duration, insulin usage, age, and tyrosine as the most important factors of both DKD and DR. DKD was additionally associated with cardiovascular disease history, antihypertensive medication use, and 3 metabolites (lactate, citrate, and cholesterol esters to total lipids ratio in intermediate-density lipoprotein), while DR was additionally associated with hemoglobin A 1c , blood glucose, pulse pressure, and alanine. Machine-learned models for DKD and DR detection outperformed traditional LR models in both internal (AUC 0.838 vs 0.743 for DKD and 0.790 vs 0.764 for DR) and external validation (AUC 0.791 vs 0.691 for DKD and 0.778 vs 0.760 for DR). Conclusions: This study highlighted diabetes duration, insulin usage, age, and circulating tyrosine as important factors in detecting DKD and DR. The integration of ML with biomedical big data enables biomarker discovery and improves disease detection beyond traditional risk factors.

Construction and evaluation of a metabolic correlation diagnostic model for diabetes based on machine learning algorithms

A Machine Learning-Based Diagnosis Modelling of Type 2 Diabetes Mellitus with Environmental Metal Exposure

Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients

Identification of Type 2 Diabetes Based on a Ten-Gene Biomarker Prediction Model Constructed Using a Support Vector Machine Algorithm

Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis

Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics

Development and External Validation of Machine Learning Models for Diabetic Microvascular Complications: Cross-Sectional Study With Metabolites

Machine Learning Reveals Metabolic Signatures in Patients with Type 1 Diabetes

Development and validation of machine learning-augmented algorithm for insulin sensitivity assessment in the community and primary care settings: a population-based study in China

Development of Multimarker Diagnostic Models from Metabolomics Analysis for Gestational Diabetes Mellitus (GDM).

Research on Diabetes Risk Prediction Model at Early Stage Based on Machine Learning

Developing Discriminate Model and Comparative Analysis of Differentially Expressed Genes and Pathways for Bloodstream Samples of Diabetes Mellitus Type 2.

A Three-gene-based Type 1 Diabetes Diagnostic Signature

Interpretable Machine Learning-Derived Nomogram Model for Early Detection of Diabetic Retinopathy in Type 2 Diabetes Mellitus: a Widely Targeted Metabolomics Study

Identification of diagnostic genes for both Alzheimer's disease and Metabolic syndrome by the machine learning algorithm

Identification of diagnostic markers related to oxidative stress and inflammatory response in diabetic kidney disease by machine learning algorithms: Evidence from human transcriptomic data and mouse experiments

Metabolism-related biomarkers, molecular classification, and immune infiltration in diabetic ulcers with validation

Machine learning-based identification and validation of immune-related biomarkers for early diagnosis and targeted therapy in diabetic retinopathy

Author Correction: Metabolic Biomarkers for Prognostic Prediction of Pre-diabetes: Results from a Longitudinal Cohort Study

Development and economic assessment of machine learning models to predict glycosylated hemoglobin in type 2 diabetes

Machine Learning Models for Diabetic Neuropathy Diagnosis Using Microcirculatory Parameters in Type 2 Diabetes Patients.